Our History
ZJKC History
Founded in 2008, ZJKC Technologies began the commercialization of Cold Laser Therapy for the elimination of chronic pain and continues this business to date.At the same time, we continue to develop new products.
ZJKC Timeline
2008
Founding & Initial Breakthrough
- March 2008 - Established in Wuhan, China, as a specialist in medical laser technology.
- Core Mission - 'To revolutionize non-invasive therapies through photonic engineering.'
- 2008-2009 - Developed first-generation 15-30W laser therapy device, pioneering portable solutions for pain relief
2010–2012
Commercialization & Global Expansion
- Launched 10+ laser therapy devices for pain relief.
- Achieved $3M USD cumulative sales across 15 countries.
- Partnered with European distributors to establish clinical validation centers in Germany and Italy.
2013–2018
Technological Leadership
- Flagship Innovation - Released 308nm UV lamp excimer laser systems for skin disease, achieving 93% repigmentation rates in clinical trials.
- Diversified into aesthetic tech with cosmetic laser masks and facial rejuvenation mats, capturing 12% of Asia's medical aesthetics device market.
- Annual sales surged to $12M USD, supplying 200+ tertiary hospitals including Wuhan Union Hospital.
2019–2022
Industrial-Grade Solutions
- Introduced 305W ultra-pulse lasers.
- Secured 23 patents for adaptive cooling systems and AI-powered dosage algorithms.
- Cumulative sales exceeded $20M USD with installations in 50+ Class III hospitals.
2023–2025
Consumer Health Revolution
- 2023 - Developed modular laser therapy carts.
- 2025 Roadmap - Deploying IoT-enabled LaserCare Ecosystem connecting clinics/home users via cloud-based treatment monitoring.
Future Vision
- By 2030, ZJKC aims to:
- ➤ Develop personalized laser gene therapy platforms targeting hereditary conditions
- ➤ Reduce global reliance on opioid painkillers through accessible laser analgesia
